Skip to main content

Advertisement

Log in

Effect of compound Zhuye Shigao Granule (复方竹叶石膏 颗粒) on acute radiation-induced esophagitis in cancer patients: A randomized controlled trial

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the efficacy and safety of the Chinese medicine (CM) Compound Zhuye Shigao Granule (复方竹叶石膏颗粒, CZSG) on acute radiation-induced esophagitis (ARIE) in cancer patients.

Methods

In a blinded, randomized, Kangfuxin Solution (康复新液, KFX)-controlled, single-centre clinical trial, 120 patients with lung, esophagus or mediastinal cancer were prospectively enrolled and assigned to the treatment group (60 cases) and control group (60 cases) by the random number table method. All patients received concurrent or sequential radiotherapy (2 Gy per day, 5 times per week, for 4 weeks) and were treated for 4 weeks since the radiation therapy. Patients in the treatment group were given 12 mg CZSG orally, thrice daily, while patients in the control group were given 10 mL KFX orally, thrice daily. The major indicators were observed, including the incidence and grade of esophagitis, time of occurrence and duration. Minor indicators were changes of CM symptoms, weight and Karnofsky Performance Status (KPS) Scale during 4 weeks from the beginning, recorded once a week. Blood routine examination and hepatorenal function were detected at the 2nd and 4th weeks.

Results

The incidence and grade of ARIE were significantly decreased in the treatment group compared with the control group (P<0.05). CZSG appeared to significantly delay the time of ARIE occurrence and reduce the duration compared with KFX (P<0.05). The scores of CM symptoms, KPS and weight were improved significantly in the treatment group compared with the control group (P<0.05). There were no blood routine and hepatorenal function abnormal or obvious side-effects in both groups. Hemoglobin was improved and neutrophil and interleukin 6 were decreased in both groups after 4-week treatment compared with before treatment (P<0.05), and there was no significant difference between the two groups (P>0.05).

Conclusions

CZSG can decrease the incidence and grade of ARIE, delay the time of occurrence, reduce duration and alleviate the damage of ARIE. It is safe and effective in the prevention and cure of ARIE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Diana M, Shriram J. Radiation esophagitis. Arch Pathol Lab Med 2015;139:826–830.

    Google Scholar 

  2. Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 2013;87:690–696.

    Article  PubMed  Google Scholar 

  3. Auperin A, Le C, Rolland E. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181–2190.

    Article  CAS  PubMed  Google Scholar 

  4. Topkan E, Yavuz MN, Onal C, Yavuz AA. Prevention of acute radiation-induced esophagitis with glutamine in nonsmall cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. Lung Cancer 2009;63:393–399.

    Article  PubMed  Google Scholar 

  5. Bar-Ad V, Ohri N, Werner-Wasik M. Esophagitis, treatmentrelated toxicity in non-small cell lung cancer. Rev Recent Clin Trials 2012;7:31–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Choi GB, Shin JH, Song HY. Fluoroscopically guided balloon dilation for patients with esophageal stricture after radiation treatment. J Vasc Interv Radiol 2005;16:1705–1710.

    Article  PubMed  Google Scholar 

  7. Feng M, Smith DE, Normolle DP. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys 2012;83:1441–1447.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lu JZ, Zhao H, Liu Y, Feng LC. Clinical study on prevention and treatment for acute radiation esophagitis by Modified Lophatheri and Gypsi Fibrosi Decoction. China J Tradit Chin Med Pharm (Chin) 2010;25:59–62.

    Google Scholar 

  9. Lu JZ, Wang C, Cao XT, Yang MH, Zhao H, Liu Y. Effect of Zhuye Shigao Granule on tumor necrosis factor-a and interleukins serum protein levels in rats with radiation esophagitis. J Tradit Chin Med (Chin) 2014;34:338–341.

    Article  Google Scholar 

  10. Lu JZ, Zhao L, Ren JP, Cao XT. Preventive and therapeutic effects of Chinese herbal medicine Compound Zhuye Shigao Granule in rats with radiation-induced esophagitis. J Chin Integr Med (Chin) 2011;9:435–441.

    Article  Google Scholar 

  11. China Food and Drug Administration. Good clinical practice. [S/OL]. (2003-08-06) [2014-09-17] Available at: http://www.sfda.gov.cn/WS01/CL0053/24473.html.

  12. Cox JD, Stez J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–1346.

    Article  CAS  PubMed  Google Scholar 

  13. Zhao H, Xie P, Li X, Zhu W, Sun XD, Sun XR, et al. A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer. Radiother Oncol 2015;114:351–356.

    Article  PubMed  Google Scholar 

  14. Sun YD. Effects of Huisheng Koufuye in prevention and treatment of acute radiation-induced esophagitis. World Chin J Digestol 2014;22:3019.

    Article  Google Scholar 

  15. Zhang Z, Xu J, Zhou T, Yi Y, Li H. Risk factors of radiationinduced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy. Radiat Oncol 2014;9:54–61.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lu JZ, Wang C, Yang MH, Zhao H, Liu Y, Cao XT. Effect of Modified Zhuye Shigao Decoction and its components on preventing radiation esophagitis of rats. Chin J Integr Med 2014;20:462–467.

    Article  CAS  PubMed  Google Scholar 

  17. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet 2015;387:907–916.

    Article  PubMed  Google Scholar 

  18. Lin HL, Li GJ, Wu JZ. Effect of aluminum phosphate gel and Kangfuxin on esophageal pathology and IL-8 and PGE2 expressions in a rat model of reflux esophagitis. J South Med Uni 2015;35:573–577.

    Google Scholar 

  19. Wu SB, Bai HM, Chen JZ, Zhang CB, Bao SX. Effect of Kangfuxin Liquid in the treatment of 60 cases with radiation esophagitis. Jinlin Med (Chin) 2010;31:5730–5731.

    Google Scholar 

  20. Qiu XL, Yang M, Xie XL, Lai J, Chen SW. In vivo/in vitro evaluation of Kangfuxin Colon Targeting Capsules. China J Chin Mater Med (Chin) 2007;32:1644–1647.

    CAS  Google Scholar 

  21. Luo TZ, Gao MT, Ma FF, Liu GM, Zhang CJ. Research advances in phmacological action and clinical application of Periplaneta americana. Agricult Sci Technol 2012;13:888–892.

    Google Scholar 

  22. Jiang Y, Wang X, Jin C, Chen X, Li J, Wu Z, et al. Inhibitory effect of Periplaneta americana extract on 3LL lung cancer in mice. Chin J Lung Cancer (Chin) 2006;9:488–491.

    Google Scholar 

  23. Lin J, Wei L, Shen A, Cai Q, Xu W, Li H, et al. Hedyotis diffusa Willd extract suppresses Sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis. Int J Oncol 2013;42:651–656.

    PubMed  Google Scholar 

  24. Dai ZJ, Liu XX, Ji ZZ, Liu L, Kang HF, Wang XJ, et al. The effect-enhancing and toxicity-reducing action of the extract of Herba Scutellariae barbatae for chemotherapy in hepatoma H22 tumor-bearing mice. J Tradit Chin Med 2008;28:205–210.

    Article  PubMed  Google Scholar 

  25. Tang Q, Shao M, Wang Y, Zhao H, Fan C, Huang X, et al. Simultaneous determination of 10 bioactive components of Lophatherum gracile Brongn by HPLC-DAD. J Chromatogr Sci 2015;53:963–967.

    Article  CAS  PubMed  Google Scholar 

  26. You Q, Ma ZC, Wang YG, Hu DH, Liang QD, Xiao CR, et al. Panax ginseng inhibits intestinal absorption of toxic Aconitum carmichaeli alkaloids in vitro. Chin J Integr Med 2015. DOI: 10.1007/s11655-015-2282-3

    Google Scholar 

  27. Zu G, Wang H, Wang J, Dou Y, Zhao W, Sun Y. Rhizoma Pinelliae trypsin inhibitor separation, purification and inhibitory activity on the proliferation of BGC-823 gastric adenocarcinoma cells. Exp Ther Med 2014;8:248–254.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Hu YC, Xie YM, Yang W, Wang YY, Wang LX, Tang H, et al. Clinical characteristics research of Shenmai Injection treating tumor based on hospital information system in real world. China J Chin Mater Med (Chin) 2014;39:3509–3513.

    Google Scholar 

  29. Yu JY, Ha JY, Kim KM, Jung YS, Jung JC, Oh S. Antiinflammatory activities of licorice extract and its active compounds, glycyrrhizicacid, liquiritin and liquiritigenin in BV2 cells and mice liver. Molecules 2015;20:13041–13054.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. WANG Chen (Department of Chinese Medicine, Chinese PLA General Hospital) for reading, commenting and correcting the manuscript and CAO Xiu-tang (Department of Statistical, Chinese PLA General Hospital) for advices of statistical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun-zhang Lu.

Additional information

Supported by the National Natural Science Foundation of China (No. 81373543) and Clinical Research Support Fund of the PLA General Hospital (No. 2013FC-ZHCG-1002)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Lj., Lu, Jz., Cai, Bn. et al. Effect of compound Zhuye Shigao Granule (复方竹叶石膏 颗粒) on acute radiation-induced esophagitis in cancer patients: A randomized controlled trial. Chin. J. Integr. Med. 23, 98–104 (2017). https://doi.org/10.1007/s11655-016-2652-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-016-2652-5

Keywords

Navigation